… renal cell carcinoma treated in the period 2002 to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations
M Lindskog, T Wahlgren, R Sandin, J Kowalski… - … Oncology: Seminars and …, 2017 - Elsevier
… benefits of nephrectomy and TT, respectively, for the elderly population and in M1 patients
… of fit patients. Importantly, however, our results indicate that synchronous metastases at RCC …
… of fit patients. Importantly, however, our results indicate that synchronous metastases at RCC …
[HTML][HTML] Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
K Hemminki, A Försti, A Hemminki, B Ljungberg… - PLoS …, 2021 - journals.plos.org
… survival experience in Finland and Sweden over a period of … 1987–1991 and then declined
to the starting level; after 2002 … patients had distant metastases and the mean tumor size was …
to the starting level; after 2002 … patients had distant metastases and the mean tumor size was …
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist, P Lindblad… - … journal of urology, 2020 - Taylor & Francis
… to the Swedish National Population Register for overall survival … The present study in the
early TKI era, suggests that in a … -risk patients, since all had synchronous metastatic disease […
early TKI era, suggests that in a … -risk patients, since all had synchronous metastatic disease […
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study
S Demasure, I Spriet, PR Debruyne, A Laenen… - Acta …, 2022 - Taylor & Francis
… (the cytokin era, which was in our study predominantly IFNa), … study including 4.217 Swedish
patients diagnosed with mRCC between 2002 and 2005, 2006 and 2008 or 2009 and 2012…
patients diagnosed with mRCC between 2002 and 2005, 2006 and 2008 or 2009 and 2012…
Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis
J Redig, J Dalén, U Harmenberg… - … and Research, 2019 - Taylor & Francis
… Overall survival and factors influencing overall survival in this … treated in the period 2002
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic …
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic …
[HTML][HTML] Changes in treatment reality and survival of patients with advanced clear cell renal cell carcinoma–analyses from the german clinical RCC-registry
PJ Goebell, M Staehler, L Müller, A Nusch… - … Genitourinary Cancer, 2018 - Elsevier
… Swedish RENCOMP (Renal Comparison) study that covered the time period 2002 to 2012.
… for this patient population until recently.23, 32 The Updated European Association of Urology …
… for this patient population until recently.23, 32 The Updated European Association of Urology …
[HTML][HTML] Treatment of advanced renal cell carcinoma: immunotherapies have demonstrated overall survival benefits while targeted therapies have not
O Hemminki, N Perlis, J Bjorklund, A Finelli… - European urology open …, 2020 - Elsevier
… listed as a treatment option for metastatic renal cell carcinoma in … During this time period,
indications for surgery have remained … However, an ad hoc subgroup analysis suggested no OS …
indications for surgery have remained … However, an ad hoc subgroup analysis suggested no OS …
Metastatic papillary renal cell carcinoma in the era of targeted therapy–a retrospective study from three European academic centres
M Stenman, M Staehler, B Szabados… - Acta …, 2019 - Taylor & Francis
… (n = 86) referred to three academic centres in Sweden and … The aim of the study was to
evaluate overall survival (OS) of … Moreover, for patients with synchronous metastases …
evaluate overall survival (OS) of … Moreover, for patients with synchronous metastases …
A population based study on Kidney Cancer in Norway (2008-2013). Aspects of biopsy use, surgical treatment and outcome
KM Hjelle - 2018 - bora.uib.no
… obtain updated numbers on kidney cancer (KC) treatment in … better cancer specific survival
(CSS) and overall survival (OS) [… The incidence of ipsilateral synchronous adrenal metastases …
(CSS) and overall survival (OS) [… The incidence of ipsilateral synchronous adrenal metastases …
Comparative survival associated with use of targeted vs nontargeted therapy in medicare patients with metastatic renal cell carcinoma
P Li, J Jahnke, AR Pettit, YN Wong… - JAMA Network …, 2019 - jamanetwork.com
… , 36 our subgroup analysis of patients who had undergone … 44 ; in our study, unadjusted
median overall survival for the … our study period, and a recent analysis found greater survival …
median overall survival for the … our study period, and a recent analysis found greater survival …